title: Cardiovascular risk and events in 17 low-, middle-, and high-income countries.
abstract: More than 80% of deaths from cardiovascular disease are estimated to occur in low-income and middle-income countries, but the reasons are unknown.
  
  
  
  We enrolled 156,424 persons from 628 urban and rural communities in 17 countries (3 high-income, 10 middle-income, and 4 low-income countries) and assessed their cardiovascular risk using the INTERHEART Risk Score, a validated score for quantifying risk-factor burden without the use of laboratory testing (with higher scores indicating greater risk-factor burden). Participants were followed for incident cardiovascular disease and death for a mean of 4.1 years.
  
  
  
  The mean INTERHEART Risk Score was highest in high-income countries, intermediate in middle-income countries, and lowest in low-income countries (P<0.001). However, the rates of major cardiovascular events (death from cardiovascular causes, myocardial infarction, stroke, or heart failure) were lower in high-income countries than in middle- and low-income countries (3.99 events per 1000 person-years vs. 5.38 and 6.43 events per 1000 person-years, respectively; P<0.001). Case fatality rates were also lowest in high-income countries (6.5%, 15.9%, and 17.3% in high-, middle-, and low-income countries, respectively; P=0.01). Urban communities had a higher risk-factor burden than rural communities but lower rates of cardiovascular events (4.83 vs. 6.25 events per 1000 person-years, P<0.001) and case fatality rates (13.52% vs. 17.25%, P<0.001). The use of preventive medications and revascularization procedures was significantly more common in high-income countries than in middle- or low-income countries (P<0.001).
  
  
  
  Although the risk-factor burden was lowest in low-income countries, the rates of major cardiovascular disease and death were substantially higher in low-income countries than in high-income countries. The high burden of risk factors in high-income countries may have been mitigated by better control of risk factors and more frequent use of proven pharmacologic therapies and revascularization. (Funded by the Population Health Research Institute and others.).
authors.affiliation: From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., S.R., K.T., S.I., S.A., M. McQueen), Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC (S.L.), the Department of Medicine, University of Ottawa, Ottawa, ON (A.W.), and Laval University Heart and Lungs Institute, Quebec City, QC (G.D.) - all in Canada; the National Center for Cardiovascular Diseases, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing (W.L., L.L., J.B.), Jiangsu Province Institute of Geriatrics, Jiangsu Province, Nanjing City (Q.L.), Shandong Province Academy of Medical Science, Shandong Province, Jinan City (F. Lu), Xi'an Electronic Technology University Hospital, Shanxi Province, Xi'an City (T.L.), Shenyang City 242 Hospital, Liaoning Province, Shenyang City, Huanggu District (L.Y.), Bayannaoer Center for Disease Control and Prevention, Inner Mongolia, Bayannaoer City, Linhe District, Jiefangxi (S.Z.) - all in China; the Division of Epidemiology and Population Health, St. John's Research Institute, Bangalore (P.M., S.S.), Madras Diabetes Research Foundation, Chennai (V.M.), Fortis Escorts Hospitals, JLN Marg, Jaipur (R.G.), Postgraduate Institute of Medical Education and Research School of Public Health, Chandigarh (R. Kumar), and Health Action by People, Trivandrum, Kerala (K.V.) - all in India; Estudios Clinicos Latinoamerica ECLA, Rosario, Santa Fe, Argentina (R.D.); Dante Pazzanese Institute of Cardiology, São Paulo (A.A.); Fundacion Oftalmologica de Santander (FOSCAL), Medical School, Universidad de Santander, Floridablanca-Santander, Colombia (P.L.-J.); Universidad de La Frontera, Temuco, Chile (F. Lanas); Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, and UCSI University Kuala Lumpur, Kuala Lumpur (K.Y.), and the Department of Community Health, University Kebangsaan Malaysia Medical Centre, Kuala Lumpur (N.I.) - all in Malay
authors.forename: Salim
authors.initials: S
authors.lastname: Yusuf
authors.forename: Sumathy
authors.initials: S
authors.lastname: Rangarajan
authors.forename: Koon
authors.initials: K
authors.lastname: Teo
authors.forename: Shofiqul
authors.initials: S
authors.lastname: Islam
authors.forename: Wei
authors.initials: W
authors.lastname: Li
authors.forename: Lisheng
authors.initials: L
authors.lastname: Liu
authors.forename: Jian
authors.initials: J
authors.lastname: Bo
authors.forename: Qinglin
authors.initials: Q
authors.lastname: Lou
authors.forename: Fanghong
authors.initials: F
authors.lastname: Lu
authors.forename: Tianlu
authors.initials: T
authors.lastname: Liu
authors.forename: Liu
authors.initials: L
authors.lastname: Yu
authors.forename: Shiying
authors.initials: S
authors.lastname: Zhang
authors.forename: Prem
authors.initials: P
authors.lastname: Mony
authors.forename: Sumathi
authors.initials: S
authors.lastname: Swaminathan
authors.forename: Viswanathan
authors.initials: V
authors.lastname: Mohan
authors.forename: Rajeev
authors.initials: R
authors.lastname: Gupta
authors.forename: Rajesh
authors.initials: R
authors.lastname: Kumar
authors.forename: Krishnapillai
authors.initials: K
authors.lastname: Vijayakumar
authors.forename: Scott
authors.initials: S
authors.lastname: Lear
authors.forename: Sonia
authors.initials: S
authors.lastname: Anand
authors.forename: Andreas
authors.initials: A
authors.lastname: Wielgosz
authors.forename: Rafael
authors.initials: R
authors.lastname: Diaz
authors.forename: Alvaro
authors.initials: A
authors.lastname: Avezum
authors.forename: Patricio
authors.initials: P
authors.lastname: Lopez-Jaramillo
authors.forename: Fernando
authors.initials: F
authors.lastname: Lanas
authors.forename: Khalid
authors.initials: K
authors.lastname: Yusoff
authors.forename: Noorhassim
authors.initials: N
authors.lastname: Ismail
authors.forename: Romaina
authors.initials: R
authors.lastname: Iqbal
authors.forename: Omar
authors.initials: O
authors.lastname: Rahman
authors.forename: Annika
authors.initials: A
authors.lastname: Rosengren
authors.forename: Afzalhussein
authors.initials: A
authors.lastname: Yusufali
authors.forename: Roya
authors.initials: R
authors.lastname: Kelishadi
authors.forename: Annamarie
authors.initials: A
authors.lastname: Kruger
authors.forename: Thandi
authors.initials: T
authors.lastname: Puoane
authors.forename: Andrzej
authors.initials: A
authors.lastname: Szuba
authors.forename: Jephat
authors.initials: J
authors.lastname: Chifamba
authors.forename: Aytekin
authors.initials: A
authors.lastname: Oguz
authors.forename: Matthew
authors.initials: M
authors.lastname: McQueen
authors.forename: Martin
authors.initials: M
authors.lastname: McKee
authors.forename: Gilles
authors.initials: G
authors.lastname: Dagenais
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000401:mortality*; D005260:Female; D014943:Global Health; D006801:Humans; D007182:Income; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012307:Risk Factors; D012423:Rural Health; D014504:Urban Health